Skip to main content

Research Repository

Advanced Search

Phenotypic characterization of breast cancer: the role of CDC42

Chrysanthou, Eleni; Gorringe, Kylie L.; Joseph, Chitra; Craze, Madeleine L.; Nolan, Christopher C.; Diez-Rodriguez, Maria; Green, Andrew R.; Rakha, Emad A.; Ellis, Ian O.; Mukherjee, Abhik

Phenotypic characterization of breast cancer: the role of CDC42 Thumbnail


Authors

Eleni Chrysanthou

Kylie L. Gorringe

Madeleine L. Craze

Christopher C. Nolan

Maria Diez-Rodriguez

Andrew R. Green

Emad A. Rakha

Ian O. Ellis



Abstract

Purpose: The molecular landscape of breast cancer (BC), especially of the Luminal A subtype, remains to be fully delineated. Transcriptomic data shows that Luminal A tumours are enriched for aberrant expression of genes in the cell division control 42 homolog (CDC42) pathway. This study aims to investigate protein expression of CDC42 in BC and assess its clinicopathological significance.
Methods: Expression of CDC42 protein was examined by immunohistochemistry on tissue microarrays in a well characterised cohort of 895 early stage (I-IIIa) primary invasive BCs.
Results: CDC42 expression was observed in both the cytoplasm and nucleus of BC cells. High nuclear CDC42 expression demonstrated a significant correlation with ER positive, low-grade tumours and was more common in the lobular histological subtype (all p<0.001). In contrast, cytoplasmic CDC42 showed increased expression in the ductal subtype (p<0.001) and correlated with negative prognostic features such as larger size, higher grade (p<0.05), and higher Ki67 labelling index (p=0.001). Nuclear CDC42 expression was associated with a longer BC specific survival in all cases (p=0.025) and in luminal ER positive tumours (p=0.011). In multivariate analyses including size, grade, lymph node stage and intrinsic subtype, CDC42 was an independent prognostic factor (p=0.032).
Conclusion: The results indicate that CDC42 is important molecule in luminal BC, with prognostic significance.

Citation

Chrysanthou, E., Gorringe, K. L., Joseph, C., Craze, M. L., Nolan, C. C., Diez-Rodriguez, M., Green, A. R., Rakha, E. A., Ellis, I. O., & Mukherjee, A. (2017). Phenotypic characterization of breast cancer: the role of CDC42. Breast Cancer Research and Treatment, 164(2), https://doi.org/10.1007/s10549-017-4267-8

Journal Article Type Article
Acceptance Date Mar 30, 2017
Online Publication Date Apr 27, 2017
Publication Date Jul 31, 2017
Deposit Date May 4, 2017
Publicly Available Date May 4, 2017
Journal Breast Cancer Research and Treatment
Print ISSN 0167-6806
Electronic ISSN 1573-7217
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 164
Issue 2
DOI https://doi.org/10.1007/s10549-017-4267-8
Keywords CDC42, Immunohistochemistry, Luminal breast cancer, prognosis
Public URL https://nottingham-repository.worktribe.com/output/874942
Publisher URL https://link.springer.com/article/10.1007%2Fs10549-017-4267-8
Contract Date May 4, 2017

Files






You might also like



Downloadable Citations